Neratinib
3144A1-2205 / B1891016
Phase 1 small_molecule completed
Quick answer
Neratinib for Neoplasms is a Phase 1 program (small_molecule) at PUMA BIOTECHNOLOGY, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- PUMA BIOTECHNOLOGY, INC.
- Indication
- Neoplasms
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed